Investigating the Use of BAN2401 (A? mAb) in Treatment of Alzheimer Disease
Verified
Added on 2022/11/22
|10
|3149
|197
AI Summary
This study investigates the impact of the use of BAN2401 (A? mAb) in treatment of Alzheimer Disease to improve the lives of many affected Australians. The study design, methods, and primary and secondary outcome measures are discussed.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.